Trending NewsTrending NewsNYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $29.46 +0.18 (+0.61%) Closing price 09/25/2026 03:59 PM EasternExtended Trading$29.36 -0.10 (-0.32%) As of 09/25/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Hims & Hers Health Stock (NYSE:HIMS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Hims & Hers Health alerts:Sign Up Key Stats Today's Range$28.57▼$29.7650-Day Range$24.97▼$33.6752-Week Range$13.74▼$65.30Volume8.19 million shsAverage Volume9.41 million shsMarket Capitalization$6.87 billionP/E RatioN/ADividend YieldN/APrice Target$32.43Consensus RatingHold Company Overview Hims & Hers Health, Inc. is a direct-to-consumer health and wellness company that provides access to personalized care through digital platforms, including the Hims and Hers brands. The company connects consumers with licensed healthcare professionals for online consultations, treatment plans and prescription medications, where appropriate. Its services address areas such as sexual health, hair loss, skin care, mental health, weight management and primary care. Hims & Hers also offers over-the-counter products, supplements and personal-care items, with products and prescriptions delivered directly to customers through its fulfillment network and pharmacy partners. The company was established in 2016 and initially focused on men’s health before expanding under the Hers brand to serve women and broaden its health-care offerings. Hims & Hers serves customers primarily in the United States, with operations also available in select international markets. Andrew Dudum is the company’s co-founder and chief executive officer.AI Generated. May Contain Errors. Read More Hims & Hers Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScoreHIMS MarketRank™: Hims & Hers Health scored higher than 41% of companies evaluated by MarketBeat, and ranked 659th out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingHold Consensus RatingHims & Hers Health has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on no strong buy ratings, 3 buy ratings, 12 hold ratings, and 1 sell rating.Upside PotentialHims & Hers Health has a consensus price target of $32.43, representing about 10.1% upside from its current price of $29.46.Amount of Analyst CoverageHims & Hers Health has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Hims & Hers Health are expected to grow in the coming year, from ($0.16) to $0.44 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is -46.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is -46.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 12.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Hims & Hers Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted25.71% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 6.13.Change versus previous monthShort interest in Hims & Hers Health has recently decreased by 3.69%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.08 News SentimentHims & Hers Health has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 47 news articles for Hims & Hers Health this week, compared to 8 articles on an average week.Search InterestOnly 39 people have searched for HIMS on MarketBeat in the last 30 days. This is a decrease of -42% compared to the previous 30 days.MarketBeat Follows18 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 38% compared to the previous 30 days. Company Ownership1.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,731,869.00 in company stock.Percentage Held by Insiders11.76% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HIMS Stock News HeadlinesCan Hims & Hers Health (HIMS) Stay Cheap As Sales Face Scrutiny?3 hours ago | finance.yahoo.comHims & Hers Health, Inc. (NYSE:HIMS) Stock Has Average Price Target of $32.43 According to BrokeragesSeptember 27 at 2:28 AM | americanbankingnews.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.September 27 at 1:00 AM | Stansberry Research (Ad)Why Hims & Hers Health (HIMS) Is Back In The SpotlightSeptember 26 at 8:01 PM | finance.yahoo.comHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of RisksHims & Hers Health shares fell 6.7% amid an FTC lawsuit over privacy and billing practices, a new securities class action, and a Q2 earnings miss that has weighed on the stock in 2026.September 24 at 2:30 PM | marketbeat.comIs the Market Right or Wrong About These 4 High Short Interest Stocks? (HIMS)HIMS, ONDS, COIN, and SOFI show elevated short interest, but days-to-cover ratios, institutional ownership, and upcoming earnings reports suggest differing outlooks for short sellers.September 24 at 9:45 AM | marketbeat.comHims & Hers Health (NYSE:HIMS) CFO Oluyemi Okupe Sells 29,277 Shares of StockSeptember 24 at 5:37 AM | insidertrades.comHims & Hers Health (NYSE:HIMS) CFO Sells 12,313 SharesSeptember 19, 2026 | insidertrades.comSee More Headlines HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $32.45 at the beginning of the year. Since then, HIMS shares have decreased by 9.2% and is now trading at $29.46. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) issued its earnings results on Monday, August, 10th. The company reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.32. The business's revenue for the quarter was up 38.2% on a year-over-year basis. Read the conference call transcript. Is Hims & Hers Health doing a stock buyback? Hims & Hers Health's Board of Directors initiated a stock buyback plan on Monday, November 17th 2025, which permits the company to buy back $250,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 3% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's board of directors believes its shares are undervalued. Who are Hims & Hers Health's major shareholders? Top institutional investors of Hims & Hers Health include Bank of New York Mellon Corp (0.58%), Bienville Capital Management LLC (0.34%), FirstWave Capital Management LLC (0.15%) and Kelly Lawrence W & Associates Inc. CA (0.14%). Insiders that own company stock include Melissa Baird, Michael Chi, Soleil Boughton, Oluyemi Okupe, David B Wells, Patrick Harrison Carroll, Christopher D Payne, Andrew Dudum, Garcia Andrea G Perez, Deborah M Autor, Christiane Pendarvis, Irene Becklund, Irene Becklund, Anja Manuel and Lynne Chou O'keefe. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Hims & Hers Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX) and Palo Alto Networks (PANW). Company Calendar Last Earnings8/10/2026Today9/27/2026Next Earnings (Estimated)11/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 HIMS's financial health is in the Green zone, according to TradeSmith. HIMS has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:HIMS CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees2,442Year Founded2017Price Target and Rating Average Price Target for Hims & Hers Health$32.43 High Price Target$60.00 Low Price Target$23.00 Potential Upside/Downside+10.1%Consensus RatingHold Rating Score (0-4)2.13 Research Coverage16 Analysts Profitability EPS (Trailing Twelve Months)($0.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$128.37 million Net Margins-5.51% Pretax Margin-6.35% Return on Equity-6.51% Return on Assets-1.20% Debt Debt-to-Equity Ratio4.21 Current Ratio0.93 Quick Ratio0.87 Sales & Book Value Annual Sales$2.58 billion Price / Sales2.67 Cash Flow$0.84 per share Price / Cash Flow35.15 Book Value$2.38 per share Price / Book12.38Miscellaneous Outstanding Shares233,313,000Free Float205,875,000Market Cap$6.87 billion OptionableOptionable Beta2.42 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSE:HIMS) was last updated on 9/27/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
